MARKET

ATRS

ATRS

Antares Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.040
+0.055
+1.38%
Opening 15:17 01/27 EST
OPEN
4.000
PREV CLOSE
3.985
HIGH
4.150
LOW
3.980
VOLUME
1.17M
TURNOVER
--
52 WEEK HIGH
5.13
52 WEEK LOW
2.600
MARKET CAP
659.43M
P/E (TTM)
-1224.2424
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ATRS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ATRS News

  • Antares Pharma Sees FY2020 Sales $135M-155M vs $149.16M Est
  • Benzinga.8h ago
  • Antares Pharma Sees FY2019 Sales $120M vs $118.26M Est
  • Benzinga.8h ago
  • Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million
  • GlobeNewswire.8h ago
  • Is Antares Pharma, Inc.'s (NASDAQ:ATRS) CEO Paid At A Competitive Rate?
  • Simply Wall St..01/16 10:59

More

Industry

Medical Equipment, Supplies & Distribution
-0.13%
Healthcare Equipment & Supplies
-0.75%

Hot Stocks

Name
Price
%Change

About ATRS

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.
More

Webull offers Antares Pharma Inc (ATRS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.